I-Mab Biopharma
IMAB
#9469
Rank
S$74.56 M
Marketcap
$0.91
Share price
-6.87%
Change (1 day)
-62.95%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$19.91 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are S$19.91 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$23.58 M-28.07%
2022-12-31S$32.78 M-5.43%
2021-12-31S$34.67 M58.03%
2020-12-31S$21.93 M-78.91%
2019-12-31S$0.10 B8.17%
2018-12-31S$96.19 M130.52%
2017-12-31S$41.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$16.35 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.12 B 5,540.68%๐Ÿ‡บ๐Ÿ‡ธ USA